US appeal court denies plea for Myblu to remain on sale during MDO challenge

Myblu vaping products will not be allowed to be sold in the US market while a court reviews a marketing denial order (MDO).

An appeal court has declined to issue an emergency stay for Fontem US in its challenge to an MDO issued by the US Food and Drug Administration (FDA). The decision is a defeat for the maker of the Myblu vaping pod that could have greater implications for it as it pursues its full court challenge, with a panel of three judges determining that it “has not made a strong showing that it is likely to succeed on the merits”.